Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

Vasodilators may worsen abdominal aortic aneurysm.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Mesalazine may help treat extensive alopecia areata effectively.

Younger patients with severe alopecia areata often have nail problems.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

The 308-nm excimer laser helps hair regrowth in some alopecia areata cases but not all.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Viral warts are common in children, so prevention against HPV is important.

The excimer lamp is a safe and effective treatment for severe alopecia areata.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

Ebastine may help regrow hair in alopecia areata patients.

New therapies are needed to reduce the burden of alopecia areata.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

Baricitinib effectively promotes hair regrowth in both scalp and nonscalp areas for alopecia areata universalis patients.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

88% phenol is effective for treating alopecia areata.